Table 1.
|
Reagent name | Antibody isotype |
Specificity |
Commercial availability |
Ref. |
||
---|---|---|---|---|---|---|---|
O -GlcNAc | β-GlcNAc | GlcNAc* | |||||
Anti-body |
CTD110.6 |
IgM |
|
+ |
|
+ |
[31] |
|
RL2 |
IgG |
+ |
|
|
+ |
[32,33] |
|
HGAC39 |
IgG |
|
+ |
|
|
[34] |
|
HGAC49 |
IgM |
|
+ |
|
|
[34] |
|
HGAC85 |
IgG |
|
+ |
|
+ |
[34] |
|
9D1.E4(10) |
IgG |
|
+ |
|
+ |
[35] |
|
18B10.C7 (3) |
IgG |
+ |
|
|
+ |
[35] |
|
1 F5.D6(14) |
IgG |
+ |
|
|
+ |
[35] |
|
My95 |
IgG |
|
|
|
|
[36] |
Lectin |
WGA/sWGA+ |
|
|
|
+ |
+ |
[38] |
GSLII | + | + | [39] |
GlcNAc*: all terminal GlcNAc including α/β-GlcNAc.
sWGA+: succinated-wheat germ agglutinin. sWGA reduces its affinity for sialic acid and GlcNAc residues. As such, sWGA is typically used for immunoblotting while WGA for purification.